If the EVOKE trial results in late 2025 show clear benefits, it could take another one to two years for FDA approval and insurance coverage decisions
Non-starchy vegetables and fruit add fullness, vitamins, and fiber that keeps digestion moving
Because many individuals request GLP-1s due to a focus on body weight, other key components in the obesity management journey must be considered and discussed before initiating these therapies
Gradual dose tapering and resumption (coordinated with your provider) reduces this rebound effect
The combination of modern and traditional tactics makes this strobe incredibly versatile
Getting protein-on-the-go Demand for protein continues to rise, in line with Innova Market Insights identifying Powerhouse Protein as its top ten trend for 2026, but this is being accelerated by the growing adoption of GLP-1 medications, which can make it more challenging to meet daily protein needs